Skip to main content

and
  1. Article

    Open Access

    Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children’s Oncology Group

    Ewing sarcoma (EWS) is an aggressive sarcoma with no validated molecular biomarkers. We aimed to determine the frequency of STAG2 protein loss by immunohistochemistry (IHC) and whether loss of expression is as...

    David S. Shulman, Sonja Chen, David Hall, Anwesha Nag in British Journal of Cancer (2022)

  2. Article

    Correction: Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

    The authors have noticed that the final paragraph of the Results section contains errors in the number of patients involved. The correct number of patients is included in the text below. These errors do not af...

    David S. Shulman, Kelly Klega, Alma Imamovic-Tuco in British Journal of Cancer (2019)

  3. Article

    Open Access

    Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

    New prognostic markers are needed to identify patients with Ewing sarcoma (EWS) and osteosarcoma unlikely to benefit from standard therapy. We describe the incidence and association with outcome of circulating...

    David S. Shulman, Kelly Klega, Alma Imamovic-Tuco in British Journal of Cancer (2018)